Submission Details
| 510(k) Number | K172601 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2017 |
| Decision Date | March 02, 2018 |
| Days to Decision | 184 days |
| Submission Type | Traditional |
| Review Panel | Physical Medicine (PM) |
| Summary | Summary PDF |
K172601 is an FDA 510(k) clearance for the Next Generation iBOT, a Wheelchair, Stair Climbing (Class II — Special Controls, product code IMK), submitted by Deka Research & Development Corp. (Manchester, US). The FDA issued a Cleared decision on March 2, 2018, 184 days after receiving the submission on August 30, 2017. This device falls under the Physical Medicine review panel. Regulated under 21 CFR 890.3890.
| 510(k) Number | K172601 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2017 |
| Decision Date | March 02, 2018 |
| Days to Decision | 184 days |
| Submission Type | Traditional |
| Review Panel | Physical Medicine (PM) |
| Summary | Summary PDF |
| Product Code | IMK — Wheelchair, Stair Climbing |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 890.3890 |
| Definition | A Device With Wheels That Is Intended For Medical Purposes To Provide Mobility To Persons Restricted To A Sitting Position. The Device Is Intended To Climb Stairs. Fda Interprets ?mobility To Persons Restricted To A Sitting Position? To Mean The Device Type Is Intended To Provide Mobility To Individuals Who Have Mobility Impairments And Require An Assistive Device For Mobility. |